I screwed that up on the 8-k that is past money most of which is already spent.

But the offer for tendering warrants exists. Costs of the mCRC trial is dependent on trial size and trial length. 120 patients should be enough to show statistical significance but they might go 150 for margin of error. With a one year trial length it could be comfortably done for $8 to $10 million. So then we come down to how many warrants will be tendered. At 75% off especially on a downswing in share price I would expect it to be popular.